[Initial experience with the use of Levovist in adult patients with suboptimal echocardiograms].

J Mariscal-Uriarte, F Martínez-Baca, E Rosas-Munive
{"title":"[Initial experience with the use of Levovist in adult patients with suboptimal echocardiograms].","authors":"J Mariscal-Uriarte,&nbsp;F Martínez-Baca,&nbsp;E Rosas-Munive","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To report our experience with the use of Levovist in echocardiographic studies.</p><p><strong>Method: </strong>We studied consecutively patients with suboptimal echocardiographic studies. A bolus of 4 gr @ 400 mg/ml was administered via antecubital vein and a second echocardiogram was performed during the ensuing minutes.</p><p><strong>Results: </strong>Between June and July 1998 we studied 16 patients with suboptimal echocardiograms, seven males and nine females, ages 29-77. There were six patients with coronary artery disease (CAD), three with mitral regurgitation (MR), one with dynamic subaortic stenosis, five with right chambers dilatation and one with a left atrial tumor. No patient referred discomfort or had any complication-with Levovist. The mean time of the contrast effect was nine minutes. A better delineation of endocardial borders was observed this allowed better evaluation of wall motion and left ventricular function in patients with CAD. There was Doppler enhancement in patients with MR and subaortic stenosis facilitating its evaluation. We documented atrial septal defect non visualized previously in two of five patients with right chambers dilatation. There was a better delineation of the left atrial tumor.</p><p><strong>Conclusions: </strong>Levovist showed enhancement of all Doppler modalities and facilitated de evaluation of MR, left ventricular function, subaortic stenosis and a cardiac tumor. It was safe and well tolerated.</p>","PeriodicalId":75556,"journal":{"name":"Archivos del Instituto de Cardiologia de Mexico","volume":"70 2","pages":"154-9"},"PeriodicalIF":0.0000,"publicationDate":"2000-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos del Instituto de Cardiologia de Mexico","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To report our experience with the use of Levovist in echocardiographic studies.

Method: We studied consecutively patients with suboptimal echocardiographic studies. A bolus of 4 gr @ 400 mg/ml was administered via antecubital vein and a second echocardiogram was performed during the ensuing minutes.

Results: Between June and July 1998 we studied 16 patients with suboptimal echocardiograms, seven males and nine females, ages 29-77. There were six patients with coronary artery disease (CAD), three with mitral regurgitation (MR), one with dynamic subaortic stenosis, five with right chambers dilatation and one with a left atrial tumor. No patient referred discomfort or had any complication-with Levovist. The mean time of the contrast effect was nine minutes. A better delineation of endocardial borders was observed this allowed better evaluation of wall motion and left ventricular function in patients with CAD. There was Doppler enhancement in patients with MR and subaortic stenosis facilitating its evaluation. We documented atrial septal defect non visualized previously in two of five patients with right chambers dilatation. There was a better delineation of the left atrial tumor.

Conclusions: Levovist showed enhancement of all Doppler modalities and facilitated de evaluation of MR, left ventricular function, subaortic stenosis and a cardiac tumor. It was safe and well tolerated.

[超声心动图不理想的成人患者使用Levovist的初步经验]。
目的:报告我们在超声心动图研究中使用左旋仪的经验。方法:对超声心动图检查不理想的患者进行连续研究。通过肘前静脉给药4gr @ 400mg /ml,在随后的几分钟内进行第二次超声心动图检查。结果:1998年6月至7月间,我们研究了16例超声心动图次优的患者,其中男7例,女9例,年龄29-77岁。冠状动脉疾病(CAD) 6例,二尖瓣反流(MR) 3例,动态主动脉下狭窄1例,右心室扩张5例,左心房肿瘤1例。没有患者提及不适或任何并发症。对比效果的平均时间为9分钟。观察到心内膜边界的更好描绘,这可以更好地评估CAD患者的壁运动和左心室功能。MR和主动脉下狭窄患者的多普勒增强有助于其评估。我们记录了5例右心室扩张患者中的2例房间隔缺损。左心房肿瘤的轮廓较清晰。结论:Levovist显示了所有多普勒模式的增强,并促进了MR,左心室功能,主动脉下狭窄和心脏肿瘤的评估。它是安全且耐受性良好的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信